Left to right: Michael L. Riordan, the founder and Chairman of Gilead Sciences, Inc.; John C. Martin, CEO of Gilead; Professor Antonin Holy, Czech Institute of Organic Chemistry and Biochemistry; Professor Erik De Clercq, Rega Institute for Medical Research, Belgium. 1996.
